Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (901-910 of 1,700) with videos related to

Pageof 170
Sort By:
European Heart Journal|September 1, 2016
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trialKyohei Yamaji, Lorenz Räber, Thomas Zanchin, et al.
American Heart Journal|June 17, 2019
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapyElvin Kedhi, Azeem Latib, Alexandre Abizaid, et al.
Circulation. Cardiovascular Interventions|September 17, 2019
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 24, 2013
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stentsThomas Pilgrim, Bindu Kalesan, Thomas Zanchin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantationMaria D Radu, Lorenz Räber, Jungho Heo, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
Pageof 170

Showing results (901-910 of 1,700) with videos related to

Sort By:
Pageof 170
European Heart Journal|September 1, 2016
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trialKyohei Yamaji, Lorenz Räber, Thomas Zanchin, et al.
American Heart Journal|June 17, 2019
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapyElvin Kedhi, Azeem Latib, Alexandre Abizaid, et al.
Circulation. Cardiovascular Interventions|September 17, 2019
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 24, 2013
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stentsThomas Pilgrim, Bindu Kalesan, Thomas Zanchin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 26, 2013
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantationMaria D Radu, Lorenz Räber, Jungho Heo, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 2, 2010
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound studyParham Eshtehardi, Stéphane Cook, Simon Wandel, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
European Heart Journal. Acute Cardiovascular Care|July 2, 2021
'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trialAmr S Gamal, Hironori Hara, Mariusz Tomaniak, et al.
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
Pageof 170